Catalogue Search | MBRL
Search Results Heading
Explore the vast range of titles available.
MBRLSearchResults
-
DisciplineDiscipline
-
Is Peer ReviewedIs Peer Reviewed
-
Item TypeItem Type
-
SubjectSubject
-
YearFrom:-To:
-
More FiltersMore FiltersSourceLanguage
Done
Filters
Reset
6
result(s) for
"ROS-Inflammation"
Sort by:
Enzyme-like biomimetic oral-agent enabling modulating gut microbiota and restoring redox homeostasis to treat inflammatory bowel disease
2024
Reactive oxygen species (ROS), immune dysregulation-induced inflammatory outbreaks and microbial imbalance play critical roles in the development of inflammatory bowel disease (IBD). Herein, a novel enzyme-like biomimetic oral-agent ZnPBA@YCW has been developed, using yeast cell wall (YCW) as the outer shell and zinc-doped Prussian blue analogue (ZnPBA) nanozyme inside. When orally administered, the ZnPBA@YCW is able to adhere to Escherichia coli occupying the ecological niche in IBD and subsequently release the ZnPBA nanozyme for removal of E. coli, meanwhile exhibiting improved intestinal epithelial barrier repair. Moreover, it is found that the ZnPBA nanozyme exhibits remarkable capability in restoring redox homeostasis by scavenging ROS and inhibiting NF-κB signaling pathway. More importantly, the 16S ribosomal RNA gene sequencing results indicate that post-oral of ZnPBA@YCW can effectively regulate gut microbiota by enhancing the bacterial richness and diversity, significantly increasing the abundance of probiotics with anti-inflammatory phenotype while downgrading pathogenic E. coli to the same level as normal mice. Such a novel nanomedicine provides a new idea for efficient treating those ROS-mediated diseases accompanying with flora disorders.
A novel enzyme-like biomimetic oral-agent ZnPBA@YCW could successfully regulate gut flora by significantly downgrading Escherichia coli's occupied ecological niche, enhancing the bacterial biodiversity while increasing the abundance of probiotics with anti-inflammatory phenotype. Moreover, it breaks the vicious cycle of ROS-inflammation, making it a highly efficient treatment option for treating inflammatory bowel disease. [Display omitted]
•A novel enzyme-like oral-agent ZnPBA@YCW has been developed for the first time, using YCW as the outer shell and ZnPBA nanozyme inside.•ZnPBA@YCW is able to adhere to E. coli and subsequently releases ZnPBA nanozyme for removal of E. coli.•ZnPBA@YCW exhibits remarkable capability in restoring redox homeostasis.•ZnPBA@YCW can effectively regulate gut microbiome.
Journal Article
Cancer Prevention
by
Seyfried, Thomas
in
AD viewed in molecular terms, as leads to cancer prevention
,
cancer prevention
,
ketone body metabolism, mitochondria protection from ROS, inflammation
2012
This chapter contains sections titled:
Cell Phones and Cancer
Alzheimer's Disease and Cancer Risk
Ketone Metabolism Reduces Cancer Risk
Mitochondrial Enhancement Therapy
Therapeutic Fasting and Cancer Prevention
Autophagy and Autolytic Cannibalism: A Thermodynamic Approach to Cancer Prevention
Cancer Prevention by Following Restricted Ketogenic Diet
References
Book Chapter
Avocado oil alleviates non-alcoholic fatty liver disease by improving mitochondrial function, oxidative stress and inflammation in rats fed a high fat–High fructose diet
by
Christian Cortés‐Rojo
,
Alfredo Saavedra‐Molina
,
Ricardo Mejía‐Zepeda
in
Antioxidants and Free Radicals in Health and Disease
,
Biochemistry
,
Biology
2022
Journal Article